AUS
NZ
UK
CA
USA
IND
The Calmer Co International Limited (ASX:CCO) has requested the quotation of 632,988 newly issued ordinary fully paid shares on the ASX following the exercise of listed options expiring on 30 June 2026. These options, identified by the code CCOOA and exercisable at $0.006 each, were converted into ordinary shares on 3 July 2026. The company’s update, lodged on 6 July 2026, reports that the total number of quoted ordinary shares now exceeds 3.52 billion. Investors in the wellness and consumer health sector company will note that this share issuance represents a small addition to an already substantial capital base, with the CCOOA option series now completely extinguished.<\/p> <\/div>
Key Points<\/h3>
- Company: The Calmer Co International Limited (ASX:CCO)<\/li>
- 632,988 new ordinary fully paid shares issued following exercise of listed options (CCOOA)<\/li>
- Options exercised at $0.006 per share on 3 July 2026, the sole exercise date<\/li>
- Total quoted ordinary shares after quotation: 3,521,129,113<\/li>
- 1,400,000 unquoted convertible notes (CCOAB) remain outstanding<\/li>
- The CCOOA option series—listed options at $0.006 expiring 30 June 2026—has been fully extinguished<\/li>
- Investors should monitor potential conversion of remaining convertible notes (CCOAB) and its effect on share count<\/li>
<\/ul>
<\/div>
CCOOA Listed Options Exercised at $0.006 Convert to New Ordinary Shares<\/h2>
The Calmer Co International confirmed in its latest update that 632,988 listed options, trading under ASX code CCOOA, were exercised on 3 July 2026 at the exercise price of $0.006 each. Each option converted into one new ordinary fully paid share, resulting in the issuance of 632,988 new CCO shares. The company applied for quotation of these shares on 6 July 2026 to have them admitted to trading on the ASX within the existing ordinary share class.<\/p>
The options expired on 30 June 2026, with the exercise occurring immediately after expiry. The 3 July 2026 conversion date reflects settlement and processing of the exercises. The company noted that both the first and last exercise date was 3 July 2026, indicating the conversion was processed as a single event. The new shares rank equally in all respects from their issue date with existing ordinary shares.<\/p>
Proceeds from the CCOOA Option Exercise Total Approximately $3,797.93<\/h2>
The company update discloses that the 632,988 options were exercised at $0.006 each, with payment made in Australian dollars. This results in gross proceeds of approximately AUD $3,797.93 from the exercise. The securities were issued for cash consideration at the stated issue price.<\/p>
While modest relative to the company’s capital base of over 3.5 billion shares, this exercise is a routine corporate action converting an existing class of listed securities. The company did not specify any particular use for the proceeds or provide commentary on capital management in this announcement.<\/p>
Ordinary Shares on Issue Now Exceed 3.52 Billion After Quotation<\/h2>
Following quotation of the 632,988 new shares, The Calmer Co International’s total quoted ordinary fully paid shares stand at 3,521,129,113, as reflected in the issued capital table included in Part 4 of the company’s Appendix 2A filing. The company noted these figures are automatically generated and may not fully reflect the current issued capital if other filings are being processed simultaneously by ASX.<\/p>
The addition of 632,988 shares to a base exceeding 3.52 billion represents an incremental dilution well below 0.1%. Nonetheless, the share count remains an important aspect of CCO’s capital structure for investors to monitor, especially given the outstanding unquoted convertible securities.<\/p>
CCOOA Option Series Now Fully Extinguished After 30 June 2026 Expiry<\/h2>
The update confirms the CCOOA option series—listed options at $0.006 expiring 30 June 2026—has been fully converted. No further options of this class remain outstanding following this exercise, and the CCOOA code no longer exists as a separate security class.<\/p>
This marks the natural conclusion of the CCOOA option lifecycle. Listed options such as these are common in smaller ASX-listed companies, granting holders the right to acquire ordinary shares at a fixed price before expiry. Any unexercised options would have lapsed after 30 June 2026. The company did not disclose how many options, if any, lapsed unexercised.<\/p>
Unquoted Convertible Notes (CCOAB) Remain on the Balance Sheet<\/h2>
The Calmer Co International’s capital structure also includes 1,400,000 unquoted convertible notes under ASX code CCOAB. These securities are not traded on ASX like ordinary shares or listed options. The company did not provide further details regarding terms, maturity, conversion ratios, or conditions for these convertible notes in this update.<\/p>
Investors and analysts should consider the CCOAB notes as a potential future source of additional ordinary shares, depending on their conversion terms. Conversion would increase the ordinary share count. However, specific conversion terms—such as trigger events, prices, and timelines—were not disclosed here. Interested parties should consult prior announcements or the company’s prospectus for more information.<\/p>
New Shares Rank Equally With Existing Ordinary Shares From Issue Date<\/h2>
The Appendix 2A filing confirms the 632,988 new shares issued from the CCOOA option exercise rank equally in all respects with existing ordinary fully paid shares from their issue date. This entitles new shareholders to identical rights, including voting and dividend participation.<\/p>
The issue date is recorded as 3 July 2026, matching the option exercise date. The company applied for quotation on 6 July 2026, and once admitted, these shares will be part of the broader CCO ordinary share pool. The filing does not disclose whether the options were exercised by one or multiple holders or identify any specific optionholder.<\/p>
Options Were Not Issued Under an Employee Incentive Scheme<\/h2>
The filing specifies that the CCOOA options were not issued under an employee incentive scheme. This distinction matters because options issued under such schemes are subject to different ASX Listing Rule requirements and escrow conditions. These listed options, tradeable on ASX under the CCOOA code, are market-facing securities rather than staff incentives.<\/p>
Options of this type are typically issued to investors as part of capital raisings, entitlement offers, or placements, often as standalone or attached securities providing additional upside. The company did not disclose the original issuance circumstances or capital-raising structure for the CCOOA options in this filing.<\/p>
Implications of the Appendix 2A Filing for CCO Shareholders<\/h2>
The Appendix 2A is a standard ASX form used to apply for quotation of new securities. Filing it is a routine administrative step required before new securities can trade. For CCO shareholders, this filing confirms the 632,988 shares from the CCOOA option exercise have been formally issued and will soon be tradable alongside existing shares.<\/p>
No shareholder approval is required to quote securities issued through exercise of previously approved listed options. The process is procedural, confirming legal and administrative conditions for trading are met. The immediate impact on share price was not evident from public information at filing time.<\/p>
About The Calmer Co International and Its ASX Securities<\/h2>
The Calmer Co International Limited is listed on ASX under ticker CCO and registered with ABN 40 169 441 874. According to this update, the company has 3,521,129,113 ordinary fully paid shares as its primary quoted security, alongside 1,400,000 unquoted convertible notes under code CCOAB. This filing was limited to administrative matters related to the quotation of new shares and did not include operational or business commentary.<\/p>
Investors seeking a deeper understanding of The Calmer Co International’s business, financial position, and strategy should consult the company’s latest annual report, quarterly activity reports, and other ASX disclosures. This update solely concerns the routine conversion of listed options and the resulting increase in ordinary shares, without addressing earnings, revenue, product development, or other operational issues.<\/p>
CCOOA Listed Options Exercised at $0.006 Convert to New Ordinary Shares<\/h2>
The Calmer Co International confirmed in its latest update that 632,988 listed options, trading under ASX code CCOOA, were exercised on 3 July 2026 at the exercise price of $0.006 each. Each option converted into one new ordinary fully paid share, resulting in the issuance of 632,988 new CCO shares. The company applied for quotation of these shares on 6 July 2026 to have them admitted to trading on the ASX within the existing ordinary share class.<\/p>
The options expired on 30 June 2026, with the exercise occurring immediately after expiry. The 3 July 2026 conversion date reflects settlement and processing of the exercises. The company noted that both the first and last exercise date was 3 July 2026, indicating the conversion was processed as a single event. The new shares rank equally in all respects from their issue date with existing ordinary shares.<\/p>
Proceeds from the CCOOA Option Exercise Total Approximately $3,797.93<\/h2>
The company update discloses that the 632,988 options were exercised at $0.006 each, with payment made in Australian dollars. This results in gross proceeds of approximately AUD $3,797.93 from the exercise. The securities were issued for cash consideration at the stated issue price.<\/p>
While modest relative to the company’s capital base of over 3.5 billion shares, this exercise is a routine corporate action converting an existing class of listed securities. The company did not specify any particular use for the proceeds or provide commentary on capital management in this announcement.<\/p>
Ordinary Shares on Issue Now Exceed 3.52 Billion After Quotation<\/h2>
Following quotation of the 632,988 new shares, The Calmer Co International’s total quoted ordinary fully paid shares stand at 3,521,129,113, as reflected in the issued capital table included in Part 4 of the company’s Appendix 2A filing. The company noted these figures are automatically generated and may not fully reflect the current issued capital if other filings are being processed simultaneously by ASX.<\/p>
The addition of 632,988 shares to a base exceeding 3.52 billion represents an incremental dilution well below 0.1%. Nonetheless, the share count remains an important aspect of CCO’s capital structure for investors to monitor, especially given the outstanding unquoted convertible securities.<\/p>
CCOOA Option Series Now Fully Extinguished After 30 June 2026 Expiry<\/h2>
The update confirms the CCOOA option series—listed options at $0.006 expiring 30 June 2026—has been fully converted. No further options of this class remain outstanding following this exercise, and the CCOOA code no longer exists as a separate security class.<\/p>
This marks the natural conclusion of the CCOOA option lifecycle. Listed options such as these are common in smaller ASX-listed companies, granting holders the right to acquire ordinary shares at a fixed price before expiry. Any unexercised options would have lapsed after 30 June 2026. The company did not disclose how many options, if any, lapsed unexercised.<\/p>
Unquoted Convertible Notes (CCOAB) Remain on the Balance Sheet<\/h2>
The Calmer Co International’s capital structure also includes 1,400,000 unquoted convertible notes under ASX code CCOAB. These securities are not traded on ASX like ordinary shares or listed options. The company did not provide further details regarding terms, maturity, conversion ratios, or conditions for these convertible notes in this update.<\/p>
Investors and analysts should consider the CCOAB notes as a potential future source of additional ordinary shares, depending on their conversion terms. Conversion would increase the ordinary share count. However, specific conversion terms—such as trigger events, prices, and timelines—were not disclosed here. Interested parties should consult prior announcements or the company’s prospectus for more information.<\/p>
New Shares Rank Equally With Existing Ordinary Shares From Issue Date<\/h2>
The Appendix 2A filing confirms the 632,988 new shares issued from the CCOOA option exercise rank equally in all respects with existing ordinary fully paid shares from their issue date. This entitles new shareholders to identical rights, including voting and dividend participation.<\/p>
The issue date is recorded as 3 July 2026, matching the option exercise date. The company applied for quotation on 6 July 2026, and once admitted, these shares will be part of the broader CCO ordinary share pool. The filing does not disclose whether the options were exercised by one or multiple holders or identify any specific optionholder.<\/p>
Options Were Not Issued Under an Employee Incentive Scheme<\/h2>
The filing specifies that the CCOOA options were not issued under an employee incentive scheme. This distinction matters because options issued under such schemes are subject to different ASX Listing Rule requirements and escrow conditions. These listed options, tradeable on ASX under the CCOOA code, are market-facing securities rather than staff incentives.<\/p>
Options of this type are typically issued to investors as part of capital raisings, entitlement offers, or placements, often as standalone or attached securities providing additional upside. The company did not disclose the original issuance circumstances or capital-raising structure for the CCOOA options in this filing.<\/p>
Implications of the Appendix 2A Filing for CCO Shareholders<\/h2>
The Appendix 2A is a standard ASX form used to apply for quotation of new securities. Filing it is a routine administrative step required before new securities can trade. For CCO shareholders, this filing confirms the 632,988 shares from the CCOOA option exercise have been formally issued and will soon be tradable alongside existing shares.<\/p>
No shareholder approval is required to quote securities issued through exercise of previously approved listed options. The process is procedural, confirming legal and administrative conditions for trading are met. The immediate impact on share price was not evident from public information at filing time.<\/p>
About The Calmer Co International and Its ASX Securities<\/h2>
The Calmer Co International Limited is listed on ASX under ticker CCO and registered with ABN 40 169 441 874. According to this update, the company has 3,521,129,113 ordinary fully paid shares as its primary quoted security, alongside 1,400,000 unquoted convertible notes under code CCOAB. This filing was limited to administrative matters related to the quotation of new shares and did not include operational or business commentary.<\/p>
Investors seeking a deeper understanding of The Calmer Co International’s business, financial position, and strategy should consult the company’s latest annual report, quarterly activity reports, and other ASX disclosures. This update solely concerns the routine conversion of listed options and the resulting increase in ordinary shares, without addressing earnings, revenue, product development, or other operational issues.<\/p>
